NCT05326334View on ClinicalTrials.gov

THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

March 2, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

September 30, 2029

Conditions
Glioblastoma, IDH-wildtype
Trial Locations (1)

K1H 8L6

RECRUITING

The Ottawa Hospital Cancer Centre, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER